Breast and Ovarian Cancers

Prophylactic salpingo-oophorectomy reduces risk

Published in Women's Health Weekly, July 11th, 2002

by Lynn Yoffee, senior medical writer - Researchers have shown, for the first time, that women who face an increased risk of breast and ovarian cancer because of mutations in BRCA1 and BRCA2 genes can reduce their risk of these cancers if they have prophylactic salpingo-oophorectomy.

Compared with intensive ovarian screening, surgery to remove the ovaries and fallopian tubes reduced the risk of subsequent breast and ovarian cancers by 75%.

"We now have prospective evidence to present to patients so that they can make informed decisions about their care," said lead investigator Kenneth Offit, MD, chief of the clinical genetics service at Memorial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-07-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry